Jupiter Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$11.4M Sell
123,023
-47,051
-28% -$4M 0.18% 131
2020
Q1
$12.5M Sell
170,074
-80,808
-32% -$7.02M 0.24% 108
2019
Q4
$21.1M Buy
250,882
+198,922
+383% +$15.4M 0.29% 105
2019
Q3
$4.37M Sell
51,960
-143,850
-73% -$10.9M 0.06% 250
2019
Q2
$12.8M Sell
195,810
-213,246
-52% -$12.3M 0.13% 147
2019
Q1
$24.1M Buy
409,056
+123,201
+43% +$7.36M 0.22% 107
2018
Q4
$15.1M Buy
285,855
+191,759
+204% +$10.5M 0.13% 128
2018
Q3
$5.64M Buy
+94,096
New +$5.15M 0.04% 180

Other funds holding MEDP

Jupiter Investment Management's MEDP Position: Q2 2020 in Review

Jupiter Investment Management reduced its Medpace (MEDP) stake by 28% in Q2 2020, selling an estimated $4M and leaving 123,023 shares worth $11.4M. The position accounts for 0.18% of the portfolio, ranked #131.

Jupiter Investment Management first reported a position in MEDP in Q3 2018 and has held it in 8 quarters since. The position peaked at $24.1M in Q1 2019. 277 funds tracked by Wall St. Rank hold MEDP as of Q2 2020.

  • Jupiter Investment Management held 123,023 shares of Medpace worth $11.4M as of Q2 2020.
  • Jupiter Investment Management sold 47,051 Medpace shares in Q2 2020, an estimated $4M.
  • Medpace made up 0.18% of Jupiter Investment Management's portfolio in Q2 2020, its #131 holding.
  • Jupiter Investment Management first reported a position in Medpace in Q3 2018 and has held it in 8 quarters since.
  • Jupiter Investment Management's Medpace position peaked at $24.1M in Q1 2019.
  • 277 funds tracked by Wall St. Rank held Medpace as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.